Table 1.
The characteristics of the study population overall and institution type specific admittance
| N | Overall admittance to SPC | Admittance to hospital-based palliative care team/unit | Admittance to Hospice | Admittance to both hospital-based palliative care team/unit and hospice | |
|---|---|---|---|---|---|
| (%) | % | % | % | % | |
| All cancer diagnoses | 44,548 (100) | 37.4 | 26.8 | 17.3 | 6.8 |
| Sex | |||||
| Men | 23,312 (52.3) | 35.5 | 26.8 | 14.7 | 6.0 |
| Women | 21,236 (47.7) | 39.5 | 26.8 | 20.2 | 7.8 |
| Age (years) | |||||
| 18–39 | 406 (0.9) | 65.0 | 52.2 | 30.5 | 17.7 |
| 40–49 | 1,353 (3.0) | 59.7 | 46.3 | 29.3 | 16.0 |
| 50–59 | 4,521 (10.2) | 51.1 | 39.2 | 22.8 | 10.8 |
| 60–69 | 11,221 (25.2) | 44.3 | 32.5 | 20.3 | 8.5 |
| 70–79 | 13,870 (31.1) | 36.7 | 25.9 | 16.9 | 6.1 |
| 80+ | 13,177 (29.6) | 24.3 | 15.9 | 11.7 | 3.3 |
| Diagnosis (cancer site) | |||||
| Oral cavity, nasopharyngeal (etc.) (C00-C14) | 998 (2.2) | 37.7 | 30.0 | 16.2 | 8.5 |
| Oesophageal (C15) | 1,101 (2.5) | 43.0 | 32.5 | 17.3 | 6.8 |
| Stomach (C16) | 1,285 (2.9) | 47.6 | 35.4 | 22.0 | 9.9 |
| Small intestine (C17) | 162 (0.4) | 40.1 | 30.9 | 17.3 | 8.0 |
| Colorectal (C18–C20) | 5,649 (12.7) | 36.0 | 25.9 | 16.7 | 6.6 |
| Liver (etc.) (C22) | 845 (1.9) | 34.7 | 24.6 | 14.0 | 3.9 |
| Pancreatic (C25) | 2,473 (5.6) | 49.4 | 34.9 | 22.6 | 8.1 |
| Laryngeal (C32) | 280 (0.6) | 29.6 | 22.5 | 12.9 | 5.7 |
| Tracheal, bronchial and lung (C33–C34) | 10,338 (23.2) | 39.5 | 28.2 | 18.4 | 7.1 |
| Melanoma skin cancer (C43) | 774 (1.7) | 45.1 | 31.7 | 23.1 | 9.7 |
| Sarcoma (C46–C49) | 326 (0.7) | 54.9 | 40.8 | 25.8 | 11.7 |
| Breast (C50) | 3,618 (8.1) | 37.3 | 25.9 | 18.3 | 6.9 |
| Cervical (C53) | 301 (0.7) | 45.2 | 31.6 | 26.3 | 12.6 |
| Uterine (C54–55) | 499 (1.1) | 42.1 | 29.1 | 20.2 | 7.2 |
| Ovarian (etc.) (C56,C570–C574) | 1,109 (2.5) | 49.9 | 33.3 | 27.7 | 11.1 |
| Prostate (C61) | 3,512 (7.9) | 33.9 | 27.7 | 12.6 | 6.4 |
| Testicular (C62) | 39 (0.1) | 30.8 | 28.2 | 12.8 | 10.3 |
| Kidney (etc.) (C64–C66) | 991 (2.2) | 44.4 | 33.5 | 18.8 | 7.9 |
| Bladder (C67) | 1,378 (3.1) | 32.3 | 24.2 | 13.4 | 5.4 |
| Brain/central nervous system (C70–C71, C751–C753)a | 1,407 (3.2) | 40.9 | 26.0 | 22.3 | 7.4 |
| Thyroid (C73) | 114 (0.3) | 45.6 | 32.5 | 21.1 | 7.9 |
| Unknown primary cancer (C76–C80) | 1,802 (4.1) | 32.4 | 21.6 | 15.8 | 5.1 |
| Hodgkin disease (C81) | 58 (0.1) | 19.0 | 13.8 | 10.3 | 5.2 |
| Non-Hodgkin lymphoma (C82-C85) | 814 (1.8) | 20.2 | 11.7 | 11.4 | 3.0 |
| Multiple myeloma (C 90) | 635 (1.4) | 20.6 | 14.0 | 9.3 | 2.7 |
| Leukemia (C91–C95) | 1,200 (2.7) | 15.3 | 8.4 | 7.9 | 1.1 |
| Other cancer (all other C codes) | 2,840 (6.4) | 29.9 | 21.4 | 13.8 | 5.3 |
aIncluding the following D-codes: D32, D42, D330–332, D352–354, D430–432, D443–445, D333–339 and D433–439